| Billet Home Health Inc - Bullhead City | |
| 1954 Az-95 Suite 2a, Bullhead City, Arizona 86426 | |
| (833) 224-5538 | |
| Name | Billet Home Health Inc - Bullhead City |
|---|---|
| Location | 1954 Az-95 Suite 2a, Bullhead City, Arizona |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 37452 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 85224, 86401, 86409, 86413, 86426, 86429, 86440, 86442, 89029, 89084, 89148, 92363 |
| NPI Number | 1649798927 |
| Organization Name | BILLET HOME HEALTH INC - BULLHEAD CITY |
| Address | 1954 Highway 95 Ste A, Bullhead City, AZ 86442 |
| Phone Number | 833-224-5538 |
News Archive
Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.
A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.
› Verified 7 days ago
| Quality Rating: |
News Archive
Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.
A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.1 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 81.4 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.8 | 96.4 |
News Archive
Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.
A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 81.2 | 79.6 |
| How often patients got better at getting in and out of bed | 86.1 | 81.1 |
| How often patients got better at bathing | 85.4 | 82.3 |
| How often patients’ breathing improved | 84.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 96.4 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 79.1 | 75 |
| How often home health patients had to be admitted to the hospital | 13.7 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.1 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 100 | 94 |
News Archive
Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.
A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.
› Verified 7 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.
A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.
› Verified 7 days ago
The patient survey data of Billet Home Health Inc - Bullhead City is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 82 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 89 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 83 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 71 | 78 |
News Archive
Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.
A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.
› Verified 7 days ago
Mohave Home Health Location: 2020 Silver Creek Road, Building A, Suite 114, Bullhead City, Arizona 86442 Ratings: Phone: (928) 763-3184 | |
Billet Home Health Inc - Bullhead City Location: 1954 Az-95 Suite 2a, Bullhead City, Arizona 86426 Ratings: Phone: (833) 224-5538 | |
Family Care Home Health Agency Location: 2580 Highway 95, Suite 203, Bullhead City, Arizona 86442 Ratings: Phone: (702) 445-1354 |